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Abstract To determine prognostic factors of nosocomial pneumonia in general wards, we performed prospective
clinical study usingmultivariate statistical analysis.Eightypatientswith nosocomial pneumonia in our unitswere enrolled
in the study between December,1996 and January,1998.Clinical setting and severity of pneumoniawere evaluated, and
laboratory data were collected at the occurrence of nosocomial pneumonia. Death due to nosocomial pneumonia
occurred in 29 of 80 patients (mortalityrate 36%).Univariate analysis showed the following factors associatedwithmor-
tality: thepresence of anultimatelyorrapidly fatalunderlyingcondition, prior antibioticsuse, use of antacids, presence of
‘high-risk’micro-organisms, sepsis, respiratory failure,multipleorganfailure, bilateralchestX-rayin¢ltrates, a Simpli¢ed
Acute Physiology Score (SAPS) index11, albumino 3?0 gdlÿ1, andlactate dehydrogenase (LDH) 796 IUlÿ1. Further-
more, multivariate analysis identi¢ed three factors signi¢cantly associatedwithmortality: the presence of an ultimately
or rapidly fatal underlying condition [odds ratio (OR)=7?0; 95% con¢dence interval (CI)=1?2^41?1; P=0?03]; SAPS in-
dex11 (OR=7?6; 95% CI=1?1^51?9, P=0? 04); LDH 796 IUlÿ1 (OR=28?2; 95% CI=2?0^406, P=0?01).Our study in-
dicates that host factors and disease severity factors are important prognostic factors of nosocomial pneumonia in
generalwards.r2001Harcourt Publishers Ltd
doi:10.1053/rmed.2001.1201, available online athttp://www.idealibrary.comon
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Nosocomial pneumonia is a serious infection with sub-
stantialmorbidity andmortality, and is the leading cause
of death due to nosocomial infection (1,2).The annual in-
cidence is 0?5^2% of patients hospitalized, which can in-
crease up to 20-fold in ventilated patients (1,3). Because
the impact onmortality is themost important aspect of
any clinical problem, it is very important to identify fac-
tors in£uencing mortality in patients with nosocomial
pneumonia.
Several investigators have reported prognostic fac-
tors of nosocomial pneumonia in intensive care unit
(ICU) patients.Those studies showed that the following
factors are signi¢cantly related to the prognosis of pa-
tients with nosocomial pneumonia: age (4,5), a premor-
bid life style score (LSS) (6), underlying conditions (4,7),
non-surgical diagnosis (6), use of antacids or histamineReceived14 November 2001, accepted in revised form16 August 2001
and published online14 November 2001.
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0582; E-mail: osamu@kaiju.medic.kumamoto-u.ac.jptype 2 (H2) blockers (6,8), prior antibiotic use (5), inap-
propriate antibiotic therapy (9), presence of ‘high-risk’mi-
cro-organisms (4,6,10), a high Simpli¢ed Acute Physiology
Score (SAPS) index (10), the presence of respiratory fail-
ure (4), bilateral chest X-ray in¢ltrates (4,10), presence of
septic shock (10) andmultiple organ failure (MOF) (5^7).
In general, nosocomial pneumonia occurs not only in
patients in ICUs but also in those in general wards (11);
however, factors in£uencing itsprognosis in generalwards
have not been fully examined.To do so, we performed a
prospective study using multivariate statistical analysis.
Here we show that three independent factors are asso-
ciatedwithmortality: the presence of an ultimately or ra-
pidly fatal underlying condition, a high SAPS index and
elevated levels of serum lactate dehydrogenase (LDH).
METHODS
Study population
These studies were conducted at Kumamoto University
Hospital, Kumamoto, Japan, and university-a⁄liated
hospitals in Kumamoto Prefecture.Thepatients enrolled
in the study were admitted to 660-bed medical wards
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January1998.These studieswere approvedby the Institu-
tional Review Board of Kumamoto University. All
patients and/or families were informed of the purpose
of the study and gave written consent.We performed a
prospective study for 8685 patients admitted to our
units. In our study population, there were 80 cases of
nosocomial pneumonia and the incidence was estimated
at 0?9%. Ventilator associated pneumonia was not
included in the study.
De¢nitions
Cases of nosocomial pneumonia were identi¢ed by
prospective surveillance throughout the study period.
Two trained respiratory physicians were responsible for
identifying and con¢rming such cases.The presence of a
nosocomial infection and pneumonia was determined
according to the criteria of the Centers for Disease
Control (CDC) in theUnited States (12).For an infection
to be de¢ned as nosocomial, there must be no evidence
that infection was present or incubating at the time of
hospital admission. In addition, pneumonia is considered
nosocomial when its onset occurs at least 48h after ad-
mission. Nosocomial pneumonia is considered ‘causally
related to death’ when the pneumonia is not controlled
at the time of death or when the pneumonia contributes
to the death of patients su¡ering from other diseases.
Nosocomial pneumonia is not considered ‘related to
death’ when it is incidental or when the underlying
disease contributesmore signi¢cantly to death than does
the pneumonia (13).
Potential dysfunction of six organ systems (respira-
tory, cardiovascular, renal, haematologic, hepatic and
neurologic) was evaluated using the organ dysfunctions
and/or infection (ODIN) model reported by Fagon et al.
(14). MOF was de¢ned as dysfunction of more than
two organ systems. The presence of shock was
de¢ned by systolic blood pressure below 90mmHg or a
requirement for vasopressors to maintain systolic
blood pressure above 90mmHg.Coma was determined
by a score of above 6 on the GlasgowComa scale (GCS).
Respiratory failure was determined by the following
criteria: an arterial oxygen tension (PaO2) of less than
60mmHg in room air or need for ventilatory support.
LSS was de¢ned as follows: 0 indicates employed;
1, independent and fully ambulatory; 2, restricted activ-
ities; 3, housebound; and 4, bed/chair bound (5). Prior
antibiotic administration was de¢ned as intravenous
antibiotic administration for longer than 24h during any
portion of a patient’s hospitalization (5). Empiric antibio-
tic treatment was initiated according to the attending
physician’s choice, referring to the consensus statement
of the AmericanThoracic Society (ATS) (15). Antibiotic
treatment was considered adequate if the empiric drugschosen according to the recommendations of the
literature (15) were changed according to antibiotic
susceptibility reports.
Bacteriologic examination
Sputum samples were collected according to standard
procedures and management. A Gram-stain test and
a quantitative culture of sputum were performed
according to methods routinely used in medical micro-
biology laboratories. Sputum data were evaluated only
when the Gram-stain test showed numerous leukocytes
(4 25 in a100microscopic ¢eld) and fewepithelial cells
(o10 in a100microscopic ¢eld) (16).Bronchoalveolar la-
vage (BAL) and quantitative BAL £uid (BALF) cultures
were performed in nine cases. According to the study
by Jourdain et al. (17), the discriminative value of 104
cfumlÿ1was considered to be an optimal cut-o¡ point in
the quantitative BALF cultures.Micro-organisms isolated
from BALF or blood were considered to be causative
pathogens. Polymerase chain reaction (PCR) and/or im-
muno£uorescent detection of cytomegalovirus and
Pneumocystis carinii in BALF and blood were performed
in 15 cases. ‘High-risk’ micro-organisms were de¢ned as
Pseudomonas aeruginosa, Enterobacteriaceae, other
Gram-negativebacilli,Enterococcus faecalis,Staphylococcus
aureus, Candida spp, Aspergillus spp and polymicrobial
episodes of pneumonia as described by Celis et al. (4).
Data collection
Study variables of each patient were recorded and
maintained on a data collection sheet. Patient-related
variables including age, gender, pack-years of cigarette
smoking, underlying diseases, vital signs, use of corticos-
teroid/immunosuppressant/anti-cancer drugs, prior use
of antibiotics, and laboratory data were recorded in all
episodes of nosocomial pneumonia. In addition, to
analyse the factors in£uencing prognosis, we recorded
the LSS; theODINscore; the occurrence of anultimately
or rapidly fatal underlying condition according to criteria
proposed by McCabe and Jackson (18); the SAPS as the
severity index (19); GCS; and the presence or absence of
acute respiratory failure, shock, sepsis and bilateral
chest X-ray in¢ltrates. Additional factors in£uencing
outcome were also evaluated, such as use of antacids
(H2 receptor blockers) and the presence or absence of
‘high-risk’ micro-organisms. All of these parameters
were recorded within the 24h following onset of
nosocomial pneumonia.
Statistical analysis
Prognostic factors were evaluated as follows; ¢rst,
the data were compared between survivors and non-
TABLE 1 Clinical characteristics of 80 patientswith
nosocomialpneumonia
Factor No. (%)
Age (yr) 71714
Gender (male) 57 (71)
Smoker (pack-years) 27729
Alcohol abuse 4 (5)
Lifestyle score 2?371?4
Underlyingdiseases 74 (93)
Solidmalignanttumours 16 (20)
Haematologicmalignancy 18 (23)
Chronic lungdisease 21 (26)
Neurologic disease 22 (28)
Hepatic failure 4 (5)
Renal failure 4 (5)
Diabetesmellitus 14 (18)
Post-operative state 10 (13)
Numberof organ dysfunctionsby ODIN 1?071?1
SAPS index 10?473?9
Albumin (gdlÿ1) 3?070?6
LDH (IUlÿ1) 79671246
Transference to ICU 8 (10)
Death fromnosocomialpneumonia 29 (36)
Values are presented asmean7SD.
ODIN: organ dysfunction and/or infection model; SAPS:
simpli¢ed acute physiology score; LDH: lactate dehydro-
genase; ICU: intensive care unit.
TABLE 2 Micro-organisms isolated from patients with
nosocomialpneumonia
Organism No. (%)
Gram-negative 44 (55)
Pseudomonas aeruginosa 16 (20)
Pseudomonas spp 3 (4)
Enterobacteriaceae 13 (16)
Other Gram-negative rods 9 (11)
Haemophilus in£uenzae 1 (1)
Gram-positive 26 (33)
Staphylococcus aureus 17 (21)
MSSA 4 (5)
MRSA 13 (16)
Enterococci 6 (8)
Other streptococci 3 (4)
Fungi 5 (6)
Candida albicans 2 (3)‘
Candida spp 2 (3)
Aspergillus fumigatus 1 (1)
Other 3 (4)
Not identi¢ed 28 (35)
MSSA: methicillin-sensitive Staphylococcus aureus,
MRSA: methicillin-resistant Staphylococcus aureus.
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A logistic regression test was applied thereafter to
estimate the odds ratio (OR) of mortality and calculated
to the 95% con¢dence interval (CI). Second, variables
found to be signi¢cantly associated with death (Po0?05,
comparing patients who died with survivors) were
entered into a stepwise logistic regression test using
the SPSS medical software package, which allows
simultaneous control of multiple factors.
RESULTS
Table 1 shows the characteristics of 80 patients who
participated in this study. Their mean age was 71714
years, 57 of them being men and 23 women. The LSS
was 2.371.4 and 39 patients (49%) had a disability in daily
living (LSS 3). Seventy-four patients (93%) had chronic
underlying diseases, includingmalignancy.The number of
organ dysfunctions by theODINmodelwas1?071?1and
the SAPS index was 10?473?9. Eight patients were
transferred to the ICU. The majority of the patients
transferred to the ICU had ultimately or rapidly fatal
underlying conditions. Twenty-nine patients died of
nosocomial pneumonia, and the overall mortality
rate for the 80 patients who developed nosocomial
pneumoniawas 36%.
Table 2 shows microbiologic data derived from the
sputum, BALF and blood from patients with nosocomial
pneumonia. Micro-organisms were isolated from 52
cases, in which polymicrobial infections were observed
17 cases.Gram-negative bacteria (e.g.Pseudomonasaeru-
ginosa, Pseudomonas spp and Enterobacteriaceae)
were most frequently observed in these cases (55%).
Stapylococcus aureus (21%) and enterococci (8%) were
common among the gram-positive bacteria detected.
Micro-organisms isolated from BALF coincided with
those detected from blood in four cases out of nine
cases.The pro¢le of microbiologic data in this study was
similar to previous reports in Japan. The percentage of
micro-organisms categorized as ‘high-risk’ was 59%.
As shown in Table 3, the following 11 factors were
signi¢cantly di¡erent between survivors and non-
survivors in the univariate analysis: an ultimately or
rapidly fatal underlying condition, prior antibiotics use,
antacids use, thepresence of ‘high-risk’micro-organisms,
sepsis, respiratory failure, MOF, bilateral chest X-ray
in¢ltrates, a SAPS index of  11, albumin o 3?0gdlÿ1,
and LDH796 IUlÿ1.
Multivariate analysis of prognostic factors in£uenc-
ing the outcome of nosocomial pneumonia is shown in
Table 4. Stepwise logistic regression analysis indicated that
three factors are independently associated with death
from nosocomial pneumonia in general wards. These in-
clude thepresence of anultimately fatal or rapidly fatalun-
derlying condition, a SAPS index of 11 and LDH796
TABLE 3 Comparisonandunivariate analysisofclinicaldatabetweensurvivors andnon-survivorswithnosocomialpneumonia
Factor Survivors
n=51 (%)
Non-survivors
n=29 (%)
P value
Age 65 yr 28 (55) 15 (52) NS
Gender [No. males (%)] 33 (65) 24 (83) NS
Smoker 30 pack-years 19 (37) 16 (55) NS
Alcohol abuse 1 (2) 3 (10) NS
Life style score 3 22 (43) 17 (59) NS
Underlyingdiseases 45 (88) 29 (100) NS
Solidmalignanttumours 7 (14) 9 (31) NS
Haematologicalmalignancy 10 (20) 8 (28) NS
Chronic lungdisease 14 (28) 7 (24) NS
Neurologic disease 15 (29) 7 (24) NS
Hepatic failure 2 (4) 2 (7) NS
Renal failure 2 (4) 2 (7) NS
Diabetesmellitus 9 (18) 5 (17) NS
Underlyingconditions, ultimatelyor rapidly fatal 15 (29) 16 (55) o0?05
Post-operative state 6 (12) 4 (14) NS
Prior antibiotics use 20 (39) 19 (66) o0?05
Antacids use 29 (57) 24 (83) o0?05
Steroid and/or immunosuppressive therapy 8 (16) 9 (31) NS
Chemotherapy 10 (20) 8 (28) NS
High-riskmicro-organisms 24 (47) 23 (79) o0?01
Sepsis 1 (2) 8 (28) o0?01
Shock 6 (12) 5 (17) NS
Coma 3 (6) 5 (17) NS
Respiratory failure 6 (12) 14 (48) o0?01
MOF (ODIN 2) 2 (4) 19 (66) o0?01
Bilateral chest X-rayin¢ltrates 15 (29) 20 (69) o0?01
SAPS index11 17 (33) 23 (79) o0?01
White blood cells ( 20 000 oro3000mlÿ1) 13 (25) 10 (34) NS
Albumino3?0 gdlÿ1 15 (29) 15 (52) o0?05
LDH 796IU lÿ1 2 (4) 14 (48) o0.01
NS: not signi¢cant; OR: odds ratio; MOF: multiple organ failure; ODIN: organ dysfunction and/or infection model; SAPS:
simpli¢ed acute physiology score;LDH: lactate dehydrogenase.
TABLE 4 Multivariate analysis of prognostic factors in£uencing the fatal outcome
Prognostic factor OR 95% CI P value
Ultimatelyor rapidly fatalunderlyingcondition 7?0 1?2^ 41?1 0?03
SAPS index11 7?6 1?1^51?9 0?04
LDH 796 IUlÿ1 28?2 2?0 ^ 406 0?01
OR: oddsratio; 95% CI: 95% con¢dence interval; SAPS: simpli¢ed acute physiology score;LDH: lactate dehydrogenase.
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(14 cases of LDH796 IUlÿ1) included terminal stage ma-
lignancy [n=7 (50%)] andMOF [n=7 (50%)].
DISCUSSION
Despite recent advances in antibiotic chemotherapy,
nosocomial pneumonia continues to be an importantcause of mortality. The purpose of this study was to
examine the prognostic factors of nosocomial pneumo-
nia in general wards. Our study demonstrated that
the overall mortality rate of patients with nosocomial
pneumonia in general wards was 36%, a result in
agreement with previous reports (4,10). In addition,
using a univariate analysis, we found that 11 factors
were signi¢cantly di¡erent between survivors and non-
survivors: an ultimately or rapidly fatal underlying
22 RESPIRATORYMEDICINEcondition, prior antibiotics use, antacids use, ‘high-risk’
micro-organisms, sepsis, respiratory failure, MOF, bilat-
eral chest X-ray in¢ltrates, a SAPS index 11, albumin
o3?0gdlÿ1 and LDH796 IUlÿ1. Furthermore, using a
multivariate analysis, we con¢rmed that the presence of
an ultimately or rapidly fatal underlying condition, a
SAPS index11 and LDH796 IUlÿ1 are signi¢cantly
associatedwith a fatal outcome.
Several recent clinical investigations have demon-
strated various independent prognostic factors of
nosocomial pneumonia. These are classi¢ed into three
factors, including host factors, exogenous factors and
factors related to the pneumonia itself. Host factors are
age (4,5), premorbid LSS (6), underlying conditions (4, 7)
and non-surgical diagnosis (6). Exogenous factors include
antacids use (6,8), prior antibiotics use (5) and
inappropriate antibiotics use (9). Factors related to
pneumonia itself are the presence of ‘high-risk’ micro-
organisms (4,6,10),MOF (5^7), a high SAPS index (10), re-
spiratory failure (4), bilateral chest X-ray in¢ltrates (4,10)
and septic shock (10). Most of the published data de-
scribed above were derived from studies of patients in
ICUs and/or patients requiring mechanical ventilation.
As a result, the data from ICU and/or ventilator-
associated pneumonia has been generalized to all
nosocomial pneumonia.However, these factorsmay not
always apply to cases of nosocomial pneumonia seen
in patients in general wards, a group targeted by our
study.
It has been shown that the so called ‘high-risk’
microorganisms in£uence the prognosis of patients with
nosocomial pneumonia (4,6). The percentage of
‘high-risk’ micro-organisms in our study was 59% and
those were frequently isolated from non-survivors
(79%) compared to survivors (47%). These results
suggest a signi¢cant relationship between such micro-
organisms and fatality caused by nosocomial pneumonia
seen in general wards. Since we could not perform
diagnostic BAL for all the patients because of serious
conditions, micro-organisms were not identi¢ed in 28
cases (35%) in our study.
In this study, we initiated empiric antibiotic therapy
referring to the consensus statement of the American
Thoracic Society (ATS) (15). However, there was no
relationship between selected antibiotics and patient’s
prognosis (data not shown). Judging from our results, it
seems that antibiotic selection is not a major prognostic
factor of nosocomial pneumonia.
The severity of underlying conditions was a host
factor closely associated with fatality in our study. In
particular, the presence of an ultimately or rapidly fatal
underlying condition as classi¢edbyMcCabe and Jackson
was associated with a high fatality in patients with
nosocomial pneumonia in general wards. Other studies
of patients requiring mechanical ventilation and of
non-mechanical ventilation patients using multivariateanalysis arrived at the same conclusion (4,7). Taken
together, the presence of an ultimately or rapidly fatal
underlying condition is a critical host factor for the
outcome of overall nosocomial pneumonia.
The SAPSwas proposedby LeGalletal., as ameans to
simplify the acute physiology score (APS), and consists of
13 variables plus age (19). In the above study, the SAPS
was simpler and less time-consuming than the APS, and
there was no signi¢cant di¡erence between receiver
operating characteristic (ROC) curves for each score.
The accuracy and importance of SAPS for the severity
of illness scoring systems have been demonstrated in
cases of serious bacterial pneumonia (20). Moreover,
Almirall et al., showed that a SAPS index of412 is one
prognostic factor of severe pneumonias (community-
acquired and nosocomial) requiring treatment in an ICU
(10), an observation consistent with our results. Thus, a
high SAPS index is considered an e¡ective predictor of
the outcome for patients with nosocomial pneumonia.
Similar to the underlying condition and SAPS index,
our data further demonstrate the statistical signi¢cance
of serum LDH as one of three variables predicting
survival. Serum LDH has been evaluated as a marker of
disease severity in community-acquired pneumonia
and Pneumocystis carinii pneumonia with acquired immu-
node¢ciency syndrome (21,22). Ewig et al. showed that
serum LDHlevels were one of thevariablesmost closely
associated with a fatal outcome in hospital-treated,
community-acquired pneumonia (21). In our study with
nosocomial pneumonia, increased LDH levels in 14
non-survivors were due to malignancy or MOF.
Therefore, it is reasonable to conclude that elevated
LDH was derived from the malignant tumor and injur-
ed tissue, including the lung, rather than from the
pneumonia itself. Although the cause of elevated LDH is
di¡erent from previous reports described above, our
results indicate that elevated LDH levels in nosocomial
pneumonia are useful indicators of prognosis, especially
when there aremalignancies or MOF.
In summary, in a prospectivemultivariate analysis, we
have demonstrated a signi¢cant relationship between
three factors (an ultimately or rapidly fatal underlying
condition, a high SAPS index and elevated levels of LDH)
andmortality in patients with nosocomial pneumonia in
generalwards. Abetter understanding of the prognostic
factors in such patients will optimize further preventive
and therapeutic strategies in this disease and help to
decrease both itsmorbidity andmortality rates.
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